Endologix, Inc. to Present at Two Investor Conferences in November
October 29 2018 - 4:01PM
Business Wire
Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of
innovative treatments for aortic disorders, today announced that it
will present at the following two investor conferences in
November:
Conference: Stephens NY Investment ConferenceLocation: New York,
NYDate: Tuesday, November 6, 2018Presentation: 7:30 a.m.
ETSpeakers: Vaseem Mahboob, Chief Financial Officer
Conference: Stifel Healthcare ConferenceLocation: New York,
NYDate: Wednesday, November 14, 2018Presentation: 12:30 p.m.
ETSpeakers: John Onopchenko, Chief Executive Officer, and Vaseem
Mahboob, Chief Financial Officer
A live webcast of each presentation will be accessible through
the “Investors” section of the Company’s website at
www.endologix.com and will be available for replay following each
event.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's focus is
endovascular stent grafts for the treatment of abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
80%, making it a leading cause of death in the United States. For
more information, visit www.endologix.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181029005700/en/
INVESTORS:Endologix, Inc.Vaseem
Mahboob, 949-595-7200CFO
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024